These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10493310)

  • 21. Update on cancer-preventive therapeutics.
    Brenner DE
    Clin Adv Hematol Oncol; 2004 Jan; 2(1):25-6, 64. PubMed ID: 16163155
    [No Abstract]   [Full Text] [Related]  

  • 22. Tamoxifen to prevent breast cancer.
    Morrow M; Jordan VC
    Adv Surg; 2000; 34():287-99. PubMed ID: 10997224
    [No Abstract]   [Full Text] [Related]  

  • 23. [Tamoxifen in prophylaxis of breast cancer].
    Bogush TA; Bogush EA
    Antibiot Khimioter; 2001; 46(1):30-4. PubMed ID: 11221083
    [No Abstract]   [Full Text] [Related]  

  • 24. Tamoxifen prevention claim will not be allowed in USA.
    Ault A
    Lancet; 1998 Sep; 352(9131):883. PubMed ID: 9742990
    [No Abstract]   [Full Text] [Related]  

  • 25. Toward optimal health: the experts discuss tamoxifen and breast cancer prevention. Interview by Jodi Godfrey Meisler.
    Ford E; Greenwald P
    J Womens Health; 1998 Jun; 7(5):513-7. PubMed ID: 9650151
    [No Abstract]   [Full Text] [Related]  

  • 26. Breast cancer prevention. New options for patients and clinicians.
    Willett LR; August DA; Carson JL
    N J Med; 2002 Sep; 99(9):27-34. PubMed ID: 12244704
    [No Abstract]   [Full Text] [Related]  

  • 27. An overview of considerations for the testing of tamoxifen as a preventive for breast cancer.
    Jordan VC
    Ann N Y Acad Sci; 1995 Sep; 768():141-7. PubMed ID: 8526343
    [No Abstract]   [Full Text] [Related]  

  • 28. Re: tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 study.
    Love RR
    J Natl Cancer Inst; 1999 Nov; 91(21):1891-2. PubMed ID: 10547398
    [No Abstract]   [Full Text] [Related]  

  • 29. Stopping the Breast Cancer Prevention Trial.
    Gorelick KJ
    Lancet; 1998 Jun; 351(9119):1887-8. PubMed ID: 9652694
    [No Abstract]   [Full Text] [Related]  

  • 30. Tamoxifen for intraductal cancer.
    Chan KC; Bundred NJ
    Lancet; 1999 Oct; 354(9185):1211-2. PubMed ID: 10513742
    [No Abstract]   [Full Text] [Related]  

  • 31. Breast cancer chemoprevention: current clinical practice and future direction.
    Bevers TB
    Biomed Pharmacother; 2001 Nov; 55(9-10):559-64. PubMed ID: 11769967
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Results of the NSABP clinical trial for the prevention of cancer of the breast].
    Namer M
    Bull Cancer; 1998 Apr; 85(4):299. PubMed ID: 9752291
    [No Abstract]   [Full Text] [Related]  

  • 33. Another view of tamoxifen.
    Napoli M
    Am J Nurs; 2001 Apr; 101(4):33. PubMed ID: 11301681
    [No Abstract]   [Full Text] [Related]  

  • 34. Cancer chemoprevention: future holds in multiple agents.
    Mukhtar H; Ahmad N
    Toxicol Appl Pharmacol; 1999 Aug; 158(3):207-10. PubMed ID: 10438653
    [No Abstract]   [Full Text] [Related]  

  • 35. Chemoprevention of breast cancer with tamoxifen.
    Cuzick J
    IARC Sci Publ; 1996; (136):95-109. PubMed ID: 8791120
    [No Abstract]   [Full Text] [Related]  

  • 36. Recruitment of women into trials.
    Benson JR
    Lancet; 2002 Jan; 359(9301):164. PubMed ID: 11809281
    [No Abstract]   [Full Text] [Related]  

  • 37. Tamoxifen reduces risk of breast cancer in high-risk women.
    Am J Health Syst Pharm; 1998 May; 55(10):978, 981. PubMed ID: 9606443
    [No Abstract]   [Full Text] [Related]  

  • 38. Re: Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 study.
    Narod S
    J Natl Cancer Inst; 1999 Jan; 91(2):188. PubMed ID: 9923863
    [No Abstract]   [Full Text] [Related]  

  • 39. Behavioral and social factors that predict participation in the Breast Cancer Prevention Trial.
    Vernon SW; Yeomans AC; Frankowski R; Weber D; Vogel VG
    Ann N Y Acad Sci; 1995 Sep; 768():300. PubMed ID: 8526373
    [No Abstract]   [Full Text] [Related]  

  • 40. Differing Perspectives on Breast Cancer Chemoprevention.
    Jordan VC
    JAMA Oncol; 2016 Feb; 2(2):276. PubMed ID: 26868999
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.